Abstract
Our studies during the early 1970s showed that expression of GM3, the simplest ganglioside and an abundant animal cell membrane component, is reduced during malignant transformation of cells by oncogenic viruses. Levels of mRNA for GM3 synthase were reduced in avian and mammalian cells transformed by oncoprotein “v-Jun”, and overexpression of GM3 synthase in the transformed cells caused reversion from transformed to normal cell-like phenotype. GM3 has a well-documented inhibitory effect on activation of growth factor receptors (GFRs), particularly epidermal GFR (EGFR). De-N-acetyl GM3, which is expressed in some invasive human cancer cells, has an enhancing effect on EGFR activation. The important role of the sialosyl group of GM3 was demonstrated using NEU3, a plasma membrane-associated sialidase that selectively remove sialic acids from gangliosides GM3 and GD1a and is up-regulated in many human cancer cells. GM3 is highly enriched in a type of membrane microdomain termed “glycosynapse”, and forms complexes with co-localized cell signaling molecules, including Src family kinases, certain tetraspanins (e.g., CD9, CD81, CD82), integrins, and GFRs (e.g., fibroblast growth factor receptor and hepatocyte growth factor receptor c-Met). Studies by our group and others indicate that GM3 modulates cell adhesion, growth, and motility by altering molecular organization in glycosynaptic microdomains and the activation levels of co-localized signaling molecules that are involved in cancer pathogenesis.
Similar content being viewed by others
Abbreviations
- GFR:
-
Growth factor receptor
- EGFR:
-
Epidermal growth factor receptor
- GSL:
-
Glycosphingolipid
- TS:
-
Tetraspanin
- GPI:
-
Glycosylphosphatidylinositol
- GEM:
-
Glycolipid-enriched microdomain
References
Hakomori, S.: Traveling for the glycosphingolipid path. Glycoconj. J. 17(7–9), 627–647 (2000)
Hakomori, S.I.: Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim. Biophys. Acta 1780(3), 325–346 (2008). doi:10.1016/j.bbagen.2007.08.015
Hakomori, S.I., Murakami, W.T.: Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc. Natl. Acad. Sci. U. S. A. 59(1), 254–261 (1968)
Mora, P.T., Brady, R.O., Bradley, R.M., McFarland, V.W.: Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines. Proc. Natl. Acad. Sci. U. S. A. 63(4), 1290–1296 (1969)
Hakomori, S.I., Saito, T., Vogt, P.K.: Transformation by rous sarcoma virus: effects on cellular glycolipids. Virology 44(3), 609–621 (1971)
Hakomori, S.I., Wyke, J.A., Vogt, P.K.: Glycolipids of chick embryo fibroblasts infected with temperature-sensitive mutants of avian sarcoma viruses. Virology 76(2), 485–493 (1977)
Vogt, P.K.: Jun, the oncoprotein. Oncogene 20(19), 2365–2377 (2001). doi:10.1038/sj.onc.1204443
Miura, Y., Kainuma, M., Jiang, H., Velasco, H., Vogt, P.K., Hakomori, S.: Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc. Natl. Acad. Sci. U. S. A. 101(46), 16204–16209 (2004). doi:10.1073/pnas.0407297101
Ono, M., Handa, K., Sonnino, S., Withers, D.A., Nagai, H., Hakomori, S.: GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 40(21), 6414–6421 (2001)
Abercrombie, M., Ambrose, E.J.: The surface properties of cancer cells: a review. Cancer Res. 22, 525–548 (1962)
Abercrombie, M., Heaysman, J.E.: Observations on the social behaviour of cells in tissue culture. II. Monolayering of fibroblasts. Exp. Cell Res. 6(2), 293–306 (1954)
Hakomori, S.: Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cells. Proc. Natl. Acad. Sci. U. S. A. 67(4), 1741–1747 (1970)
Robbins, P.W., Macpherson, I.: Control of glycolipid synthesis in a cultured hamster cell line. Nature 229(5286), 569–570 (1971)
Sakiyama, H., Gross, S.K., Robbins, P.W.: Glycolipid synthesis in normal and virus-transformed hamster cell lines. Proc. Natl. Acad. Sci. U. S. A. 69(4), 872–876 (1972)
Lingwood, C.A., Hakomori, S.: Selective inhibition of cell growth and associated changes in glycolipid metabolism induced by monovalent antibodies to glycolipids. Exp. Cell Res. 108(2), 385–391 (1977)
Bremer, E.G., Hakomori, S.: GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: ganglioside may regulate growth factor receptor function. Biochem. Biophys. Res. Commun. 106(3), 711–718 (1982)
Bremer, E.G., Schlessinger, J., Hakomori, S.: Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 261(5), 2434–2440 (1986)
Weis, F.M., Davis, R.J.: Regulation of epidermal growth factor receptor signal transduction. Role of gangliosides. J. Biol. Chem. 265(20), 12059–12066 (1990)
Miljan, E.A., Meuillet, E.J., Mania-Farnell, B., George, D., Yamamoto, H., Simon, H.G., Bremer, E.G.: Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J. Biol. Chem. 277(12), 10108–10113 (2002). doi:10.1074/jbc.M111669200
Hanai, N., Dohi, T., Nores, G.A., Hakomori, S.: A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. J. Biol. Chem. 263(13), 6296–6301 (1988)
Hanai, N., Nores, G., Torres-Mendez, C.R., Hakomori, S.: Modified ganglioside as a possible modulator of transmembrane signaling mechanism through growth factor receptors: a preliminary note. Biochem. Biophys. Res. Commun. 147(1), 127–134 (1987)
Hanai, N., Nores, G.A., MacLeod, C., Torres-Mendez, C.R., Hakomori, S.: Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 263(22), 10915–10921 (1988)
Kawashima, N., Qu, H., Lobaton, M., Zhu, Z., Sollogoub, M., Cavenee, W.K., Handa, K., Hakomori, S.I., Zhang, Y.: Efficient synthesis of chloro-derivatives of sialosyllactosylceramide, and their enhanced inhibitory effect on epidermal growth factor receptor activation. Oncol. Lett. 7(4), 933–940 (2014). doi:10.3892/ol.2014.1887
Nores, G.A., Hanai, N., Levery, S.B., Eaton, H.L., Salyan, E.K., Hakomori, S.: Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds. Carbohydr. Res. 179, 393–410 (1988)
Nores, G.A., Hanai, N., Levery, S.B., Eaton, H.L., Salyan, M.E., Hakomori, S.: Synthesis and characterization of ganglioside GM3 derivatives: lyso-GM3, de-N-acetyl-GM3, and other compounds. Methods Enzymol. 179, 242–253 (1989)
Dohi, T., Nores, G., Hakomori, S.: An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo. Cancer Res. 48(20), 5680–5685 (1988)
Zhou, Q., Hakomori, S., Kitamura, K., Igarashi, Y.: GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J. Biol. Chem. 269(3), 1959–1965 (1994)
Liu, J.W., Sun, P., Yan, Q., Paller, A.S., Gerami, P., Ho, N., Vashi, N., Le Poole, I.C., Wang, X.Q.: De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation. Cancer Res. 69(22), 8662–8669 (2009). doi:10.1158/0008-5472.CAN-09-1099
Hakomori, S.I.: Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett. 584(9), 1901–1906 (2010). doi:10.1016/j.febslet.2009.10.065
Meuillet, E.J., Kroes, R., Yamamoto, H., Warner, T.G., Ferrari, J., Mania-Farnell, B., George, D., Rebbaa, A., Moskal, J.R., Bremer, E.G.: Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431. Cancer Res. 59(1), 234–240 (1999)
Hasegawa, T., Yamaguchi, K., Wada, T., Takeda, A., Itoyama, Y., Miyagi, T.: Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation. J. Biol. Chem. 275(11), 8007–8015 (2000)
Papini, N., Anastasia, L., Tringali, C., Croci, G., Bresciani, R., Yamaguchi, K., Miyagi, T., Preti, A., Prinetti, A., Prioni, S., Sonnino, S., Tettamanti, G., Venerando, B., Monti, E.: The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions. J. Biol. Chem. 279(17), 16989–16995 (2004). doi:10.1074/jbc.M400881200
Wada, T., Hata, K., Yamaguchi, K., Shiozaki, K., Koseki, K., Moriya, S., Miyagi, T.: A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene 26(17), 2483–2490 (2007). doi:10.1038/sj.onc.1210341
Shiozaki, K., Yamaguchi, K., Sato, I., Miyagi, T.: Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice. Cancer Sci. 100(4), 588–594 (2009). doi:10.1111/j.1349-7006.2008.01080.x
Tringali, C., Lupo, B., Silvestri, I., Papini, N., Anastasia, L., Tettamanti, G., Venerando, B.: The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling beta1 integrin internalization and recycling. J. Biol. Chem. 287(51), 42835–42845 (2012). doi:10.1074/jbc.M112.407718
Ueno, S., Saito, S., Wada, T., Yamaguchi, K., Satoh, M., Arai, Y., Miyagi, T.: Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J. Biol. Chem. 281(12), 7756–7764 (2006). doi:10.1074/jbc.M509668200
Miyata, M., Kambe, M., Tajima, O., Moriya, S., Sawaki, H., Hotta, H., Kondo, Y., Narimatsu, H., Miyagi, T., Furukawa, K., Furukawa, K.: Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides. Cancer Sci. 102(12), 2139–2149 (2011). doi:10.1111/j.1349-7006.2011.02086.x
Bonardi, D., Papini, N., Pasini, M., Dileo, L., Orizio, F., Monti, E., Caimi, L., Venerando, B., Bresciani, R.: Sialidase NEU3 dynamically associates to different membrane domains specifically modifying their ganglioside pattern and triggering Akt phosphorylation. PLoS One 9(6), e99405 (2014). doi:10.1371/journal.pone.0099405
Banda, K., Gregg, C.J., Chow, R., Varki, N.M., Varki, A.: Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid. J. Biol. Chem. 287(34), 28852–28864 (2012)
Tringali, C., Silvestri, I., Testa, F., Baldassari, P., Anastasia, L., Mortarini, R., Anichini, A., Lopez-Requena, A., Tettamanti, G., Venerando, B.: Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles. BMC Cancer 14(1), 560 (2014)
Lahera, T., Calvo, A., Torres, G., Rengifo, C.E., Quintero, S., Arango Mdel, C., Danta, D., Vázquez, J.M., Escobar, X., Carr, A.: Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer. J. Oncol. 2014 (2014)
Casadesus, A.V., Fernandez-Marrero, Y., Clavell, M., Hernandez, T., Lopez-Requena, A., Moreno, E., Gomez, J.A.: A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells. Glycoconj. J. Glycoconj. J. 30(7), 687–699 (2013)
Tillack, T.W., Allietta, M., Moran, R.E., Young Jr., W.W.: Localization of globoside and Forssman glycolipids on erythrocyte membranes. Biochim. Biophys. Acta 733(1), 15–24 (1983)
Rock, P., Allietta, M., Young Jr., W.W., Thompson, T.E., Tillack, T.W.: Ganglioside GM1 and asialo-GM1 at low concentration are preferentially incorporated into the gel phase in two-component, two-phase phosphatidylcholine bilayers. Biochemistry 30(1), 19–25 (1991)
Carter, W.G., Hakomori, S.: A new cell surface, detergent-insoluble glycoprotein matrix of human and hamster fibroblasts. The role of disulfide bonds in stabilization of the matrix. J. Biol. Chem. 256(13), 6953–6960 (1981)
Okada, Y., Mugnai, G., Bremer, E.G., Hakomori, S.: Glycosphingolipids in detergent-insoluble substrate attachment matrix (DISAM) prepared from substrate attachment material (SAM). Their possible role in regulating cell adhesion. Exp. Cell Res. 155(2), 448–456 (1984)
Simons, K., van Meer, G.: Lipid sorting in epithelial cells. Biochemistry 27(17), 6197–6202 (1988)
Brown, D.A., London, E.: Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem. Biophys. Res. Commun. 240(1), 1–7 (1997). doi:10.1006/bbrc.1997.7575
Smart, E.J., Mineo, C., Anderson, R.G.: Clustered folate receptors deliver 5-methyltetrahydrofolate to cytoplasm of MA104 cells. J. Cell Biol. 134(5), 1169–1177 (1996)
Stefanova, I., Horejsi, V., Ansotegui, I.J., Knapp, W., Stockinger, H.: GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254(5034), 1016–1019 (1991)
Kniep, B., Cinek, T., Angelisova, P., Horejsi, V.: Association of the GPI-anchored leucocyte surface glycoproteins with ganglioside GM3. Biochem. Biophys. Res. Commun. 203(2), 1069–1075 (1994)
Simons, K., Ikonen, E.: Functional rafts in cell membranes. Nature 387(6633), 569–572 (1997). doi:10.1038/42408
Handa, K., Hakomori, S.I.: Carbohydrate to carbohydrate interaction in development process and cancer progression. Glycoconj. J. 29(8–9), 627–637 (2012). doi:10.1007/s10719-012-9380-7
Kojima, N., Hakomori, S.: Specific interaction between gangliotriaosylceramide (Gg3) and sialosyllactosylceramide (GM3) as a basis for specific cellular recognition between lymphoma and melanoma cells. J. Biol. Chem. 264(34), 20159–20162 (1989)
Kojima, N., Hakomori, S.: Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction. J. Biol. Chem. 266(26), 17552–17558 (1991)
Yamamura, S., Handa, K., Hakomori, S.: A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: a preliminary note. Biochem. Biophys. Res. Commun. 236(1), 218–222 (1997)
Iwabuchi, K., Handa, K., Hakomori, S.: Separation of “glycosphingolipid signaling domain” from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J. Biol. Chem. 273(50), 33766–33773 (1998)
Prinetti, A., Iwabuchi, K., Hakomori, S.: Glycosphingolipid-enriched signaling domain in mouse neuroblastoma Neuro2a cells. Mechanism of ganglioside-dependent neuritogenesis. J. Biol. Chem. 274(30), 20916–20924 (1999)
Bromley, S.K., Burack, W.R., Johnson, K.G., Somersalo, K., Sims, T.N., Sumen, C., Davis, M.M., Shaw, A.S., Allen, P.M., Dustin, M.L.: The immunological synapse. Annu. Rev. Immunol. 19, 375–396 (2001). doi:10.1146/annurev.immunol.19.1.375
Viola, A., Schroeder, S., Sakakibara, Y., Lanzavecchia, A.: T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283(5402), 680–682 (1999)
Hakomori, S.: Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U. S. A. 99(16), 10231–10233 (2002). doi:10.1073/pnas.172380699
Ono, M., Handa, K., Withers, D.A., Hakomori, S.: Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res. 59(10), 2335–2339 (1999)
Ono, M., Handa, K., Withers, D.A., Hakomori, S.: Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. Biochem. Biophys. Res. Commun. 279(3), 744–750 (2000). doi:10.1006/bbrc.2000.4030
Folch, J., Lees, M.: Proteolipides, a new type of tissue lipoproteins; their isolation from brain. J. Biol. Chem. 191(2), 807–817 (1951)
Kawakami, Y., Kawakami, K., Steelant, W.F., Ono, M., Baek, R.C., Handa, K., Withers, D.A., Hakomori, S.: Tetraspanin CD9 is a “proteolipid,” and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J. Biol. Chem. 277(37), 34349–34358 (2002). doi:10.1074/jbc.M200771200
Lee, L., Abe, A., Shayman, J.A.: Improved inhibitors of glucosylceramide synthase. J. Biol. Chem. 274(21), 14662–14669 (1999)
Toledo, M.S., Suzuki, E., Handa, K., Hakomori, S.: Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13. J. Biol. Chem. 279(33), 34655–34664 (2004). doi:10.1074/jbc.M403857200
Mitsuzuka, K., Handa, K., Satoh, M., Arai, Y., Hakomori, S.: A specific microdomain (“glycosynapse 3”) controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J. Biol. Chem. 280(42), 35545–35553 (2005). doi:10.1074/jbc.M505630200
Birchmeier, C., Birchmeier, W., Gherardi, E., Vande Woude, G.F.: Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4(12), 915–925 (2003). doi:10.1038/nrm1261
Todeschini, A.R., Dos Santos, J.N., Handa, K., Hakomori, S.I.: Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J. Biol. Chem. 282(11), 8123–8133 (2007). doi:10.1074/jbc.M611407200
Todeschini, A.R., Dos Santos, J.N., Handa, K., Hakomori, S.I.: Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc. Natl. Acad. Sci. U. S. A. 105(6), 1925–1930 (2008). doi:10.1073/pnas.0709619104
Prinetti, A., Aureli, M., Illuzzi, G., Prioni, S., Nocco, V., Scandroglio, F., Gagliano, N., Tredici, G., Rodriguez-Menendez, V., Chigorno, V., Sonnino, S.: GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells. Glycobiology 20(1), 62–77 (2010). doi:10.1093/glycob/cwp143
Prinetti, A., Cao, T., Illuzzi, G., Prioni, S., Aureli, M., Gagliano, N., Tredici, G., Rodriguez-Menendez, V., Chigorno, V., Sonnino, S.: A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells. J. Biol. Chem. 286(47), 40900–40910 (2011)
Acknowledgments
Our studies described here were supported mainly by National Cancer Institute Outstanding Investigator Grant (OIG) CA42505 and R01 CA80054, and by The Biomembrane Institute. The authors are grateful to Dr. S. Anderson for English editing of the manuscript
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hakomori, SI., Handa, K. GM3 and cancer. Glycoconj J 32, 1–8 (2015). https://doi.org/10.1007/s10719-014-9572-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-014-9572-4